Chicago、ILにおける2型糖尿病の臨床試験
Chicagoとその周辺地域（約30マイル以内）の拠点で、2型糖尿病に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
被験者募集中第3相
- Cedar Crosse Research Center, Chicago
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
被験者募集中健康なボランティア歓迎
- Northwestern University, Chicago
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
被験者募集中第3相
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Chicago
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
被験者募集中第3相
- Research Site, Chicago
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
被験者募集中第2相
- AES - DRS - Synexus Clinical Research US, Inc. - Chicago, Chicago
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
被験者募集中第2相
- Cedar-Crosse Research Center, Chicago
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
被験者募集中第2相
- Research by Design, LLC - Internal Medicine, Chicago
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
被験者募集中第2相
- Chicago Clinical Research Institute, Chicago
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
被験者募集中第3相
- Research Site, Chicago
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Chicago
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
被験者募集中第1相健康なボランティア歓迎
- Research Site, Chicago
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
被験者募集中第3相
- University of Illinois at Chicago, Chicago
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
被験者募集中
- Northwestern University, Chicago
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
被験者募集中
- Northwestern University, Chicago
Achieving Routine Intervention and Screening for Emotional Health
被験者募集中
- University of Chicago, Chicago
Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
被験者募集中観察研究
- Illinois Institute of Technology, Chicago
Enhancing Diabetes Care: Exposome &Amp; Sensors
被験者募集中観察研究
- University of Illinois - Chicago, Chicago
- University of Illinois College of Nursing, Chicago
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
被験者募集中健康なボランティア歓迎
- University of Illinois at Chicago, Chicago
他の都市における2型糖尿病の試験
- San Antonio, TX37件の研究
- Houston, TX31件の研究
- Orlando, FL24件の研究
- Boston, MA20件の研究
- Miami, FL19件の研究
- Dallas, TX19件の研究
- Columbus, OH18件の研究
- Las Vegas, NV18件の研究
- Atlanta, GA17件の研究
- San Diego, CA17件の研究
- Los Angeles, CA16件の研究
- New York City, NY16件の研究
Chicagoにおける他の研究
- 非小細胞肺癌61件の研究
- 乳がん58件の研究
- がん（全種類）51件の研究
- 転移性癌45件の研究
- 前立腺がん45件の研究
- 肥満症41件の研究
- 肺がん41件の研究
- 卵巣がん36件の研究
- 脳卒中34件の研究
- 大腸癌33件の研究
- 心不全31件の研究
- 過体重28件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。